Provided by Tiger Trade Technology Pte. Ltd.

Cytosorbents

0.5930
-0.0071-1.18%
Post-market: 0.59300.00000.00%16:00 EDT
Volume:158.44K
Turnover:93.03K
Market Cap:37.24M
PE:-3.48
High:0.6200
Open:0.6200
Low:0.5501
Close:0.6001
52wk High:1.39
52wk Low:0.4992
Shares:62.80M
Float Shares:54.98M
Volume Ratio:1.27
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1705
EPS(LYR):-0.3806
ROE:-96.39%
ROA:-19.44%
PB:6.31
PE(LYR):-1.56

Loading ...

CytoSorbents Corporation to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 18, 2025

CytoSorbents Corporation reports Q3 2025 revenue of $9.5 million

Reuters
·
Nov 15, 2025

Cytosorbents Corp’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 15, 2025

Cytosorbents Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 14, 2025

CytoSorbents Reports Third Quarter 2025 Revenue of $9.5 Million

Reuters
·
Nov 14, 2025

Blood purification firm CytoSorbents Q3 revenue misses estimates

Reuters
·
Nov 14, 2025

CytoSorbents Q3 Revenue USD 9.485 Million

Reuters
·
Nov 14, 2025

CytoSorbents Reports 10% Revenue Growth and Improved Gross Margins in Q3 2025

Reuters
·
Nov 14, 2025

Cytosorbents Corp: Reduced Its Workforce by Approximately 10%

THOMSON REUTERS
·
Nov 14, 2025

Cytosorbents Corp: Expects to Reach Operating Cash Flow Break-Even in Q1 of 2026

THOMSON REUTERS
·
Nov 14, 2025

Cytosorbents Q3 Product Gross Margin 70%

THOMSON REUTERS
·
Nov 14, 2025

Cytosorbents Q3 Adjusted EPS USD -0.04

THOMSON REUTERS
·
Nov 14, 2025

Cytosorbents Corp: Announced Implementation of a Strategic Workforce and Cost Reduction Plan

THOMSON REUTERS
·
Nov 14, 2025

Market Cool On Cytosorbents Corporation's (NASDAQ:CTSO) Revenues Pushing Shares 31% Lower

Simply Wall St.
·
Nov 13, 2025

CytoSorbents Corporation to Participate in Jefferies Global Healthcare Conference in London

Reuters
·
Nov 11, 2025

CytoSorbents Corporation to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 30, 2025

Cytosorbents Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Oct 04, 2025

CytoSorbents Corporation Receives Nasdaq Notice for Non-Compliance with $1 Minimum Bid Price Requirement

Reuters
·
Oct 04, 2025

CytoSorbents Unveils New Clinical Trial Data on CytoSorb® and DrugSorb™-ATR for Cardiac Surgery at EACTS 2025 Annual Meeting

Reuters
·
Sep 29, 2025